L-Dopa-Decarboxylase (DDC) is a positive prognosticator for breast cancer patients and epinephrine regulates breast cancer cell (MCF7 and T47D) growth in vitro according to their different expression of Gi-protein-coupled receptors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Molecular Sciences, 21, 24, S. 9565-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg, MDPI AG
- (wann)
-
2020
- Urheber
-
Tremmel, Eileen
Kuhn, Christina
Kaltofen, Till
Vilsmaier, Theresa
Mayr, Doris
Mahner, Sven
Ditsch, Nina
Jeschke, Udo
Vattai, Aurelia
- DOI
-
10.3390/ijms21249565
- URN
-
urn:nbn:de:bvb:384-opus4-832701
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tremmel, Eileen
- Kuhn, Christina
- Kaltofen, Till
- Vilsmaier, Theresa
- Mayr, Doris
- Mahner, Sven
- Ditsch, Nina
- Jeschke, Udo
- Vattai, Aurelia
- Universität Augsburg, MDPI AG
Entstanden
- 2020
Ähnliche Objekte (12)
Immunotherapy: new options in breast cancer treatment
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Breast cancer
Breast cancer
Breast cancer
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Immunotherapy: new options in breast cancer treatment
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Breast cancer
Breast cancer
Breast cancer
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Immunotherapy: new options in breast cancer treatment
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Breast cancer
Breast cancer
Breast cancer